From Ram Cummins workhorses to Toyota Hilux legends, these diesel trucks with manual transmissions redefine what it means to ...

Eli Lilly's Mounjaro and Zepbound deliver accelerated weight loss rates compared to Novo Nordisk's Wegovy, which perhaps explains the former's triple-digit GLP-1 revenue growth on a YoY basis. This is ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional ...

Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin analogs. LLY posted a 54% YoY revenue jump and a 19% EPS beat, with ...

Revenue Growth: 54% increase compared to Q3 2024. Gross Margin: 83.6%, up 1.4 percentage points from the previous year. Research and Development Expenses: Increased by 27%. Marketing, Selling, and ...

Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...

Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here ...

About two decades after the launch of the 6.6-liter Duramax V8, GM's 3.0-liter Duramax inline-six turbodiesel arrived in 2019 with a promise to deliver "outstanding fuel economy, great horsepower, and ...

The move prompted Chief Market Strategist Shay Boloor of Futurum Equities to declare that a company like Lilly “doesn’t issue a 40-year bond unless they’re setting up for something BIG.” The ...

On Thursday, August 7, Eli Lilly's stock (NYSE:LLY) dropped by 14%, even though the company announced a strong quarter with earnings, revenues, and guidance that exceeded market expectations. This ...